Keyphrases
Activity-dependent
12%
Bell-shaped
12%
Bromo
12%
C-X-C Chemokine Receptor Type 4 (CXCR4)
25%
CD4+ Lymphocytes
100%
Cell Fusion
25%
Chemokines
12%
Chloro
12%
Co-receptor
12%
Concentration-response
12%
CXCR4 Expression
100%
Cyclohexyl
12%
Envelope Glycoprotein
12%
Flow Cytometry
12%
Fusion Expression
100%
Fusogenic Activity
12%
Galactosylated
12%
HIV Entry
12%
Human Immunodeficiency Virus Type 1 (HIV-1)
12%
In Situ
12%
Indolyl
12%
Inhibitory Activity
12%
KOR Agonists
12%
KOR Antagonist
12%
Membrane Fusion
100%
Methanesulfonate
12%
N-methylation
12%
Nor-binaltorphimine (nor-BNI)
12%
Opioid Antagonist
100%
Opioid Receptors
12%
Reporter Gene
12%
Suppression Effect
12%
Tropics
12%
U50,488
100%
Vaccinia Virus
12%
Viral Entry
12%
Viral Glycoprotein
100%
Viral Replication Cycle
12%
X-gal Staining
12%
Neuroscience
Agonist
16%
CD4
100%
Cell Fusion
33%
Chemokine
16%
Co-Receptor
16%
CXCR4
100%
Flow Cytometry
16%
Glycoprotein
100%
Human Immunodeficiency Virus
100%
Lymphocyte
100%
Membrane Fusion
100%
Receptor Agonists
100%
Reporter Gene
16%
Staining Technique
16%
Vaccinia
16%
δ -Opioid Receptor
100%
Immunology and Microbiology
Agonist
100%
CD4
100%
Cell Fusion
33%
Chemokine
16%
Chemokine Receptor CXCR4
16%
Concentration Response
16%
CXCR4
100%
down Regulation
16%
Glycoprotein
100%
Human Immunodeficiency Virus
16%
Human Immunodeficiency Virus 1
100%
Lymphocyte
100%
Membrane Fusion
100%
Reporter Gene
16%
Vaccinia Virus
16%
Viral Entry
16%
Viral Replication
16%
Pharmacology, Toxicology and Pharmaceutical Science
3,4 Dichloro N Methyl N [2 (1 Pyrrolidinyl)cyclohexyl]benzeneacetamide
100%
Chemokine
12%
Chemokine Receptor CXCR4
12%
Flow Cytometry
12%
Glycoprotein
100%
HIV
100%
Methanesulfonic Acid
12%
Opiate Agonist
100%
Opiate Receptor
12%
Vaccinia Virus
12%